A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Taurine 4g is effective with antipsychotic
medication in the treatment of First Episode Psychosis.Taurine may have an effect on
cognition and symptoms. We are examining changes in symptoms and cognition over a 3 month
period.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Melbourne Health
Collaborators:
Southern Health Stanley Medical Research Institute